03 Profile
Hansard to 11 November 2026 · 31,429 contributions indexed · 1,439 MPs & peers
All voices01 Voice · Academic · Heart disease & stroke
Vinicius de Sousa Barzon Serra
Study leader, Mayo Clinic in Scottsdale, Arizona
press citation on 1 topic since 4 Nov 2026 · last quoted 4 Nov 2026
02 Quoted on · 1 of 29 topics
Vinicius de Sousa Barzon Serra: key facts
- Kind of voice
- Academic
- Role
- Study leader, Mayo Clinic in Scottsdale, Arizona
- Quoted on
- Heart disease & stroke
- Tracked press citations
- 1
- Most recently quoted
- 4 Nov 2026
04 On the record · press
What Vinicius de Sousa Barzon Serra has said
- reuters.com1
Where Vinicius de Sousa Barzon Serra has been quoted
- 01NEWSLETTER: GLP-1 drugs help control prediabetes better than current standard medicinereuters.com · 4 Nov 2026
Verbatim
“This research may add to the case for considering GLP-1 medications earlier for certain patients, rather than waiting until they develop type 2 diabetes.”
Related media coverage
Recent UK press coverage of their topics, not necessarily citing them directly.
Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 12 Nov 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.